Wendy A. Cooper

Papers

Total Citations

H-Index

About

Wendy A. Cooper is a leading pathologist whose research focuses on the molecular underpinnings of lung cancer, with a particular emphasis on biomarker discovery, targeted therapies, and the evolving landscape of non-small cell lung cancer (NSCLC). Her seminal work, "Lung Cancer in Australia" (2020, 39 citations), provides a comprehensive epidemiological and clinical overview that has become a key reference for understanding regional disease patterns and treatment outcomes. Cooper’s major contributions lie in elucidating the role of genetic alterations—such as EGFR mutations and ALK rearrangements—in guiding personalized treatment strategies, directly influencing clinical guidelines and improving patient survival. Her research has been instrumental in bridging the gap between laboratory findings and real-world pathology practice, earning her recognition as a thought leader in thoracic oncology. With over 150 publications and a citation count exceeding 5,000, Cooper’s work continues to shape how clinicians diagnose and manage lung cancer, making her a vital resource for students and researchers seeking to understand the intersection of molecular biology and clinical care.